Rating History for Amylin Pharmaceuticals (AMLN) by Morgan Stanley

Date Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/3/2012 Upgrade Equalweight
(Underweight)
N/A
(N/A)
30.71 30.98 0.88% Details